Voyager Therapeutics (VYGR) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to -$418.5 million.
- Voyager Therapeutics' Retained Earnings fell 4346.93% to -$418.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$418.5 million, marking a year-over-year decrease of 4346.93%. This contributed to the annual value of -$326.2 million for FY2024, which is 2488.76% down from last year.
- Voyager Therapeutics' Retained Earnings amounted to -$418.5 million in Q3 2025, which was down 4346.93% from -$390.6 million recorded in Q2 2025.
- Voyager Therapeutics' 5-year Retained Earnings high stood at -$261.2 million for Q4 2023, and its period low was -$418.5 million during Q3 2025.
- Moreover, its 5-year median value for Retained Earnings was -$327.7 million (2021), whereas its average is -$332.8 million.
- In the last 5 years, Voyager Therapeutics' Retained Earnings skyrocketed by 3362.79% in 2023 and then tumbled by 4346.93% in 2025.
- Over the past 5 years, Voyager Therapeutics' Retained Earnings (Quarter) stood at -$347.1 million in 2021, then fell by 13.37% to -$393.5 million in 2022, then surged by 33.63% to -$261.2 million in 2023, then decreased by 24.89% to -$326.2 million in 2024, then dropped by 28.3% to -$418.5 million in 2025.
- Its Retained Earnings was -$418.5 million in Q3 2025, compared to -$390.6 million in Q2 2025 and -$357.2 million in Q1 2025.